| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9368066 | Anales de Pediatría | 2005 | 5 Pages |
Abstract
Somatostatin can be a safe and effective option in the treatment of both primary and secondary neonatal chylothorax refractory to conservative treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
M. González Santacruz, J.L. Tarazona Fargueta, P. Muñoz Álvarez, J. Mira Navarro, B. Jiménez Cobo,